302964-20-1

Basic information

• Product Name: Carbamic acid, [5-(chlorocarbonyl)-2-thiazolyl]-, 1,1-dimethylethyl ester (9CI)
• Synonyms: Carbamic acid, [5-(chlorocarbonyl)-2-thiazolyl]-, 1,1-dimethylethyl ester (9CI)
• CAS NO: 302964-20-1
• Molecular Formula: C₉H₁₁ClN₂O₃S
• Molecular Weight: 262.71
• Mol File: 302964-20-1.mol
• Article Data: 10

Chemical Properties

• Appearance: /
• Density: 1.400±0.06 g/cm3(Predicted)
• PKA: 4.75±0.70(Predicted)
• CAS DataBase Reference: Carbamic acid, [5-(chlorocarbonyl)-2-thiazolyl]-, 1,1-dimethylethyl ester (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [5-(chlorocarbonyl)-2-thiazolyl]-, 1,1-dimethylethyl ester (9CI)(302964-20-1)
• EPA Substance Registry System: Carbamic acid, [5-(chlorocarbonyl)-2-thiazolyl]-, 1,1-dimethylethyl ester (9CI)(302964-20-1)

Safety Data

• Hazardous Substances Data: 302964-20-1(Hazardous Substances Data)

Upstream product

• 302964-02-9 2-[(tert-butoxycarbonyl)amino]-1,3-thiazole-5-carboxylic acid 
• 24424-99-5 di-tert-butyl dicarbonate 
• 302964-01-8 ethyl 2-[(tert-butoxycarbonyl)amino]-1.3-thiazole-5-carboxylate 

Downstream Products

• 302957-97-7 [5-[[(2,4,6-trimethylphenyl)amino]carbonyl]-2-thiazolyl]carbamic acid-1,1-dimethylethyl ester 
• 302964-06-3 [5-(2-chloro-6-methylphenylcarbamoyl)thiazol-2-yl]-carbamic acid tert-butyl ester 
• 934193-04-1 [5-[[(2,6-dimethylphenyl)amino]carbonyl]-2-thiazolyl]carbamic acid 1,1-dimethylethyl ester 
• 1444001-40-4 ethyl 1-(4-((S)-5-((2-((tert-butoxycarbonyl)amino)thiazole-5-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)piperidine-2-carboxylate 
• 1444001-41-5 ethyl 1-(4-((S)-5-((2-((tert-butoxycarbonyl)amino)thiazole-5-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)-2-oxopiperidine-4-carboxylate 
• 1444001-42-6 ethyl 1-(4-((S)-5-((2-((tert-butoxycarbonyl)amino)thiazole-5-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)-3-methyl-2-oxopiperidine-3-carboxylate 
• 1444001-05-1 (S)-ethyl 1-(4-(5-((2-((tert-butoxycarbonyl)amino)thiazole-5-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)piperidine-4-carboxylate 

Relevant articles and documents

Scalable and impurity-free process for dasatinib: Src and BCR-Abl inhibitor

An efficient, telescopic, impurity-free and scalable process for Bcr-Abl and Src family tyrosine kinase inhibitor for synthesis of Dasatinib with high yield and purity is described.

A convenient new and efficient commercial synthetic route for dasatinib (Sprycel)

A new and efficient synthetic route for dual-Src/Abl kinase inhibitor dasatinib (Sprycel), an anticancer drug, is described. This commercially viable process yields dasatinib monohydrate free of potential impurities with consistent yield of 68% in route A and 61% in route B with HPLC purity >99.80% over four stages.

PYRIDINONE AND PYRIMIDINONE DERIVATIVES AS FACTOR XIA INHIBITORS

The present invention provides compounds of the general formula (I), their salts and N- oxides, and solvates and prodrugs thereof (wherein the characters are as defined in the description). The compounds of the general formula (I) are inhibitors of Factor XIa, so that they are useful in the prevention of and/or therapy for thromboembolic diseases.